entinostat has been researched along with Kidney Failure, Chronic in 1 studies
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rossi, L | 1 |
| Battistelli, C | 1 |
| de Turris, V | 1 |
| Noce, V | 1 |
| Zwergel, C | 1 |
| Valente, S | 1 |
| Moioli, A | 1 |
| Manzione, A | 1 |
| Palladino, M | 1 |
| Bordoni, V | 1 |
| Domenici, A | 1 |
| Menè, P | 1 |
| Mai, A | 1 |
| Tripodi, M | 1 |
| Strippoli, R | 1 |
1 other study available for entinostat and Kidney Failure, Chronic
| Article | Year |
|---|---|
HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal.
Topics: Aged; Aged, 80 and over; Benzamides; Cadherins; Cell Movement; Epithelial Cells; Epithelial-Mesenchy | 2018 |